LabGenomics's latest marketcap:
As of 07/07/2025, LabGenomics's market capitalization has reached $122.12 M. According to our data, LabGenomics is the 23416th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 122.12 M |
| Revenue (ttm) | 61.53 M |
| Net Income (ttm) | -14,114,750.67 |
| Shares Out | 74.24 M |
| EPS (ttm) | -0.19 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
LabGenomics's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/07/2025 | ₩122.12 M | -4.42% | 23416 |
| 12/30/2024 | ₩184.86 B | -35.41% | 21901 |
| 12/28/2023 | ₩286.2 B | 33.64% | 18231 |
| 12/29/2022 | ₩214.15 B | -23.76% | 19014 |
| 12/30/2021 | ₩280.9 B | 31.47% | 17870 |
| 12/30/2020 | ₩213.66 B | 297.75% | 16862 |
| 12/30/2019 | ₩53.72 B | -5.43% | 22342 |
| 12/28/2018 | ₩56.8 B | -68% | 20875 |
| 12/28/2017 | ₩177.5 B | 0% | 15478 |
| 12/29/2016 | ₩177.5 B | 47.1% | 14187 |
Company Profile
About LabGenomics Co., Ltd.
LabGenomics Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of innovative diagnostic solutions. Headquartered in Seongnam-si, South Korea, the company has been at the forefront of medical advancements since its founding in 2002.
Core Activities
- Biotechnology R&D: Focused on pioneering research to develop cutting-edge diagnostic technologies.
- Diagnostic Devices: Engaged in the manufacturing and distribution of high-quality diagnostic equipment.
Company Overview
LabGenomics combines scientific expertise with a commitment to improving healthcare outcomes. Its products and innovations contribute to the global medical community, enhancing diagnostic accuracy and efficiency.
Frequently Asked Questions
-
What is LabGenomics's (KOSDAQ-084650) current market cap?As of 07/07/2025, LabGenomics (including the parent company, if applicable) has an estimated market capitalization of $122.12 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does LabGenomics (KOSDAQ-084650) rank globally by market cap?LabGenomics global market capitalization ranking is approximately 23416 as of 07/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.